Form 8-K - Current report:
SEC Accession No. 0001564590-21-042616
Filing Date
2021-08-09
Accepted
2021-08-09 16:05:37
Documents
13
Period of Report
2021-08-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-8k_20210809.htm   iXBRL 8-K 46163
2 EX-99.1 fgen-ex991_6.htm EX-99.1 338953
  Complete submission text file 0001564590-21-042616.txt   528633

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA fgen-20210809.xsd EX-101.SCH 5776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE fgen-20210809_lab.xml EX-101.LAB 18732
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fgen-20210809_pre.xml EX-101.PRE 11173
6 EXTRACTED XBRL INSTANCE DOCUMENT fgen-8k_20210809_htm.xml XML 3406
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 211156438
SIC: 2834 Pharmaceutical Preparations